Diabetes mellitus has become one of the most pressing non-communicable disease challenges of the 21st century, and its burden falls disproportionately on developing countries. According to the International Diabetes Federation, over 75% of adults with diabetes live in low- and middle-income countries, where healthcare systems are often under-resourced and fragmented. Remote diabetes care—encompassing telemedicine, mobile health applications, and wearable monitoring devices—offers a promising avenue to bridge gaps in access, education, and continuity of care. However, the path to effective implementation is strewn with formidable obstacles that require careful navigation. This article examines both the barriers and the opportunities that define remote diabetes care in developing nations, offering a roadmap for stakeholders who aim to improve outcomes for millions of patients.

The Growing Burden of Diabetes in Developing Nations

Diabetes prevalence is rising faster in developing countries than in high-income nations. Rapid urbanization, dietary shifts toward processed foods, and increasingly sedentary lifestyles have fueled an epidemic of type 2 diabetes. The World Health Organization (WHO) estimates that diabetes directly caused 1.5 million deaths in 2019, and a disproportionate share occurred in low- and middle-income regions. Compounding the problem, many patients in these areas remain undiagnosed—often until complications such as retinopathy, kidney failure, or lower-limb amputations become severe. Limited access to regular screening and consistent follow-up care means that even those who are diagnosed frequently struggle to maintain glycemic control.

The economic toll is staggering. Diabetes care consumes a significant portion of already strained health budgets, and out-of-pocket expenses can push families into poverty. In this context, remote care models are not merely convenient—they may be essential for achieving equitable, sustainable management of the disease. Yet the same factors that make diabetes a crisis in developing countries also make deploying remote solutions uniquely challenging.

Key Challenges in Delivering Remote Diabetes Care

Infrastructure Deficits

The most fundamental barrier to remote diabetes care is the lack of reliable telecommunications and electrical infrastructure. Large swaths of rural sub-Saharan Africa, South Asia, and parts of Latin America still have limited or no internet connectivity. According to data from the International Telecommunication Union, only about 36% of households in developing countries had internet access at home in 2022, compared to 89% in developed nations. Even where mobile networks exist, bandwidth may be too low to support video consultations or real-time data transmission from continuous glucose monitors (CGMs).

Electricity availability is another critical bottleneck. Many health clinics and patients’ homes experience frequent power outages, making it impossible to charge devices or maintain cloud-based health records. Remote care solutions that rely solely on high-speed internet and constant power supply will fail in these settings. Alternate approaches—such as SMS-based interventions, offline-capable apps, and solar-powered devices—are necessary but often less sophisticated, limiting the types of care that can be delivered.

Workforce and Training Gaps

Even when technology is available, a shortage of trained healthcare professionals undermines remote diabetes management. Developing countries often have fewer than one physician per 1,000 people, and specialists such as endocrinologists and diabetes educators are even scarcer. Remote care requires providers to interpret data from digital tools, communicate effectively through non-traditional channels, and maintain patient engagement without physical contact. These skills are rarely taught in current medical curricula, and continuing professional development opportunities are limited.

Beyond clinical training, health workers may be skeptical about the reliability and utility of remote care platforms. Mistrust in technology, fear of added workload, and concerns about data security can impede adoption. Retaining staff who are proficient in digital health is another challenge, as trained personnel are often lured to better-resourced urban centers or abroad. Without sustained investment in human capital, any remote care initiative risks becoming a short-lived pilot project rather than a scalable solution.

Patient Digital Literacy and Engagement

For remote care to succeed, patients must be able to use the technology provided. However, digital literacy in many developing countries remains low, especially among older adults who are most at risk for diabetes. A recent study published in JMIR Diabetes found that patients with limited literacy and numeracy skills struggled to operate glucometers with Bluetooth connectivity or to understand data dashboards in diabetes management apps. Language barriers also play a role: most health apps are designed in English or other dominant languages, while many patients speak only local dialects.

Moreover, cultural attitudes toward self-management can affect engagement. In some communities, diabetes is still perceived as a disease that only doctors can manage, and patients may be reluctant to take an active role in monitoring their own blood glucose. Remote care models that do not account for these social and educational factors risk low adherence and poor outcomes. Effective interventions must include in-person or remote training, culturally tailored content, and mechanisms for ongoing support—elements that are often underfunded or overlooked.

Regulatory and Data Privacy Concerns

The digital health landscape in developing countries is often shaped by outdated or absent regulatory frameworks. Questions about data ownership, consent, and security remain unresolved. Many countries lack clear laws governing how patient data collected through remote monitoring can be stored, transmitted, and used. This ambiguity discourages investment by technology companies and healthcare providers, who fear liability or reputational damage.

Additionally, the risk of data breaches and misuse is heightened in settings where cybersecurity infrastructure is weak. Patients may be hesitant to share sensitive health information if they do not trust that it will remain confidential. Governments must develop and enforce data protection regulations that balance innovation with patients’ rights. Without such guardrails, the promise of remote diabetes care may be overshadowed by privacy violations and erosion of trust.

Promising Opportunities and Innovative Solutions

Despite the challenges, a growing body of evidence demonstrates that remote diabetes care can be effective in developing countries when implemented thoughtfully. The key is to design solutions that are appropriate for the local context, leveraging existing strengths and creatively overcoming limitations.

Leveraging Mobile Technology and SMS

Feature phones and basic smartphones with SMS capabilities are widely available even in low-resource settings. Simple text-message programs can deliver medication reminders, dietary guidance, and motivational messages at scale. For example, the “mDiabetes” program in India used automated SMS to provide weekly tips on diet, exercise, and glucose monitoring, reaching millions of patients at a very low cost per person. A randomized controlled trial published in The Lancet Digital Health found that participants receiving SMS interventions had modest but significant improvements in HbA1c levels compared to controls.

More advanced mobile apps that do not require constant internet connectivity—by storing data locally and syncing when a signal becomes available—can support self-monitoring and provide educational resources. In Bangladesh, the “Arogya” app allows diabetes patients to log blood glucose readings via a simple interface, with alerts sent to a central server for analysis. Such approaches reduce dependence on high-bandwidth infrastructure while still enabling data collection for clinical decision-making.

Telemedicine and Virtual Consultations

Video consultations are becoming more feasible as mobile network coverage expands, especially in urban and peri-urban areas. Telemedicine can connect patients in remote clinics with specialists at regional hospitals, avoiding the cost and time of long-distance travel. For routine follow-ups, such as reviewing glucose logs or adjusting medication doses, virtual visits can be as effective as in-person appointments when combined with home glucose monitoring.

However, telediabetes programs must be designed with low bandwidth in mind. Asynchronous messaging (where patients send data and questions, and providers respond within hours) is often more practical than real-time video in areas with unreliable connectivity. In Ghana, the “Tele-Diabetes” project uses a store-and-forward model: community health workers capture patient data and transmit it to a central electronic health record, where endocrinologists review cases and provide treatment recommendations. This approach optimizes the scarce time of specialists while maintaining continuity of care.

Continuous Glucose Monitoring and Wearables

CGM technology, once limited to high-income countries, is becoming more affordable and accessible. Devices such as flash glucose monitors (e.g., Abbott’s FreeStyle Libre) do not require fingerstick calibration, making them easier to use in settings where test strips and lancets are scarce. Some programs have distributed CGM sensors to patients in rural Kenya and Uganda, with promising results in reducing hypoglycemic episodes and improving time-in-range.

However, cost remains a barrier. A single CGM sensor may represent a month’s wage for many families. To make wearable monitoring viable, governments and NGOs can negotiate bulk pricing, partner with manufacturers, or subsidize devices for high-risk patients. Additionally, devices that rely on rechargeable batteries are preferable to those requiring disposable batteries, given the challenges of waste management and supply chains in remote areas.

Artificial Intelligence for Predictive Analytics

Machine learning algorithms can analyze patterns in glucose data, lifestyle logs, and demographic information to predict which patients are at risk of complications and require immediate intervention. In developing countries, where the ratio of patients to providers is extremely high, AI-driven triage can help prioritize limited resources. For instance, a model trained on local data might flag a patient whose glucose variability suggests impending diabetic ketoacidosis, prompting a nurse outreach call.

AI can also support clinical decision-making at the point of care. In Thailand, the “SmartDiabetes” platform uses an algorithm to recommend insulin dose adjustments based on a patient’s recent glucose readings, reducing the burden on physicians. Nevertheless, AI systems must be trained on diverse datasets to avoid bias, and their recommendations must be validated in real-world settings before widespread use. Data scarcity in many developing countries remains a hurdle, but ongoing collaborations between hospitals and research institutions are beginning to fill this gap.

Empowering Community Health Workers

Perhaps the most scalable opportunity lies in combining remote technology with the existing community health worker (CHW) networks that many developing countries have already built. CHWs can be equipped with smartphones or tablets running simple apps that guide them through patient assessments, provide decision-support prompts, and enable secure messaging with supervising clinicians. This model extends the reach of specialist care into villages and households without requiring every patient to own a device.

In Rwanda, the “Partners In Health” program trained CHWs to conduct home visits for diabetes patients, using a mobile app to record blood pressure, glucose, and medication adherence. The app also delivered reminders and educational videos tailored to the patient’s language and literacy level. An evaluation showed that patients under CHW-led remote management had better blood glucose control than those receiving standard clinic-based care. Such programs demonstrate that when technology empowers frontline workers rather than replacing them, outcomes improve across the board.

The Path Forward: Collaboration and Investment

No single organization can solve the challenges of remote diabetes care in developing countries. Successful scale-up requires coordinated action among governments, international donors, technology companies, healthcare providers, and local communities. Governments must commit to improving broadband connectivity and electricity access, perhaps by partnering with telecom providers to extend coverage to rural areas. They should also create regulatory sandboxes that allow pilot projects to test innovative care models without being hampered by outdated rules.

International organizations such as the WHO, the World Bank, and the International Diabetes Federation can provide technical guidance and funding. For example, the WHO’s Global Diabetes Compact aims to increase access to diabetes medicines and technologies, including digital tools, in underserved regions. Private-sector partners, including device manufacturers and health-tech startups, need to design products specifically for low-resource settings—prioritizing durability, simplicity, and affordability over feature-rich complexity.

Finally, any remote care initiative must be co-designed with end users. Engaging patients and community health workers in the design and testing of apps and devices ensures that solutions are culturally acceptable and actually meet real needs. Continuous monitoring of outcomes, including not only glycemic control but also patient satisfaction and equity of access, will allow programs to iterate and improve over time.

Conclusion

Remote diabetes care in developing countries stands at a crossroads. The obstacles are significant—infrastructure gaps, workforce shortages, low digital literacy, and regulatory vacuums—but so are the opportunities. With thoughtful adaptation, technology can extend the reach of scarce specialists, empower patients to take control of their health, and enable data-driven population health management. The experiences of pilot programs in India, Rwanda, Ghana, and elsewhere show that remote care can work when it is designed for the context in which it operates rather than copied from high-income models.

The cost of inaction is high. If diabetes continues to be managed only through overburdened clinics and episodic acute care, millions will suffer preventable complications and premature deaths. Remote care is not a panacea, but it is an essential tool in the effort to achieve universal health coverage for diabetes and other non-communicable diseases. By investing in infrastructure, training, and collaborative innovation, stakeholders can turn the promise of remote diabetes care into a reality for the communities that need it most.